Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
Windtree has manufacturing contacts that we believe are capable of reducing pharmaceutical product cost of goods for PHEXXI. Pursuant to the License and Supply Agreement, Windtree will serve as the ...
Currax Secures Reliable and Consistent Supply of CONTRAVE®/MYSBIMA with FDA Approval for Second Manufacturing Site
Currax Pharmaceuticals LLC ("Currax"), a specialty pharmaceutical company and manufacturer of the #1 branded oral weight loss medication CONTRAVE® (naltrexone HCl/bupropion HCl today announced that ...
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and Recurrent Glioblastoma ...
Food Safety News8h
Food industry mounts pushback against RFK Jr.’s artificial dye crackdown
The U.S. food industry is firmly opposing Robert F. Kennedy Jr.’s aggressive effort to eliminate artificial dyes, following his March 10 meeting with ...
After IVF nightmares, patients have few protections
An NBC News analysis found hundreds of lawsuits over five years alleging that embryos were lost, destroyed or swapped by ...
This cutting edge hair loss treatment is a repurposed drug from the 1990s
Rogaine was approved by the Food and Drug Administration in 1988, the first drug to win the agency’s endorsement for male ...
Zacks Investment Research on MSN21h
FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review
Dr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...
BizPac Review1d
Stephen Moore: The FDA can save lives by keeping copycat drugs off the market
The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold ...
Stockhead1d
Biocurious: FDA approval remains the Holy Grail for ASX life science stocks
Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.
The FDA can save lives by keeping copycat drugs off the market
The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...
Independent Journal Review1dOpinion
STEPHEN MOORE: FDA Can Save Lives By Keeping Copycat Drugs Away From Market
For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...